We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$228B
AUM Growth
-$15.4B
Cap. Flow
-$1.28B
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.8%
Holding
11,885
New
1,174
Increased
4,828
Reduced
3,849
Closed
1,024

Sector Composition

Rank Sector Weight
1 Technology 10.88%
2 Financials 6.67%
3 Healthcare 6.52%
4 Consumer Discretionary 4.99%
5 Industrials 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYCR
11001
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-105
Closed -$3K
PEV
11002
DELISTED
Phoenix Motor Inc. Common Stock
PEV
-852
Closed -$4K
GBBKW
11003
DELISTED
Global Blockchain Acquisition Corp. Warrant
GBBKW
$0 ﹤0.01%
1,470
-1,100
-43% -$58
CLRCW
11004
DELISTED
ClimateRock Warrant
CLRCW
$0 ﹤0.01%
+100
New +$7
NVRO
11005
PUT
DELISTED
NEVRO CORP.
NVRO
-2,500
Closed -$110K
TBNK
11006
DELISTED
Territorial Bancorp Inc.
TBNK
-674
Closed -$14K
CYTH
11007
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
-793
Closed -$2K
CYTHW
11008
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$0 ﹤0.01%
1,037
BACK
11009
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$0 ﹤0.01%
32
-295
-90% -$6.28K
GDSTW
11010
DELISTED
Goldenstone Acquisition Limited Warrants
GDSTW
$0 ﹤0.01%
1,639
-1
-0.1%
GDSTR
11011
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$0 ﹤0.01%
+200
New +$31
EGF
11012
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$0 ﹤0.01%
6
WINVW
11013
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$0 ﹤0.01%
900
SYRS
11014
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$0 ﹤0.01%
50
-109
-69% -$886
BNIXR
11015
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$0 ﹤0.01%
1,002
-100
-9% -$7
MYNA
11016
DELISTED
Mynaric AG American Depository Shares
MYNA
$0 ﹤0.01%
+91
New +$690
RFAC
11017
DELISTED
RF Acquisition Corp. Class A Common Stock
RFAC
-22
Closed
RFACR
11018
DELISTED
RF Acquisition Corp. Rights
RFACR
$0 ﹤0.01%
+80
New +$7
SNAXW
11019
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$0 ﹤0.01%
+8,728
New +$744
PROC
11020
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
-50
Closed
CRKN
11021
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
-$6K
GOEVW
11022
DELISTED
Canoo Inc. Warrant
GOEVW
-8,921
Closed -$3K
USAP
11023
DELISTED
Universal Stainless & Alloy
USAP
-3,479
Closed -$26K
TETEU
11024
DELISTED
Technology & Telecommunication Acquisition Corporation Unit
TETEU
$0 ﹤0.01%
25
-950
-97% -$9.61K
WAVSU
11025
DELISTED
Western Acquisition Ventures Corp. Unit
WAVSU
$0 ﹤0.01%
30

Similar funds

UBS Group's Q3 2022 Portfolio in Review

As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2022 filing shows 1,174 new, 4,828 increased, 3,849 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
  • UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
  • UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
  • UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
  • UBS Group opened 1,174 new positions and closed 1,024 in Q3 2022.
  • UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.